Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ArcticZymes Technologies ASA ( (DE:B4V) ) has provided an announcement.
ArcticZymes Technologies ASA has announced a share buyback program to support its share-based incentive programs for employees and management, allowing them to acquire shares at a 15% discount from the market price. The buyback, which will be conducted in compliance with EU regulations to ensure market integrity, involves acquiring up to 31,365 shares with a maximum total consideration of NOK 3.1 million, and is set to occur between November 25 and December 5, 2025, on the Oslo Stock Exchange.
More about ArcticZymes Technologies ASA
ArcticZymes Technologies ASA, headquartered in Tromsø, Norway, is a publicly listed company specializing in the provision of novel and high-quality enzymes for molecular research, diagnostics, and biomanufacturing. With over 30 years of expertise, the company focuses on developing and manufacturing salt-active nucleases and other specialty enzymes inspired by the Arctic environment, ensuring robust performance under demanding conditions. ArcticZymes is certified to ISO 13485 and adheres to relevant ICH GMP standards.
Average Trading Volume: 39,302
Current Market Cap: NOK1.13B
Find detailed analytics on B4V stock on TipRanks’ Stock Analysis page.